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Background: Abernethy malformation is a very rare congenital vascular malformation defined by diversion of
portal blood away from liver. It is commonly associated with multiple congenital anomalies. We present a case of
Abernethy malformation, without associated congenital anomalies from India.
Case presentation: A 5-year-old female child presented with short history of jaundice. A provisional diagnosis of
acute viral hepatitis was made in view of clinical presentation and local endemicity of viral hepatitis A. Persistence
of jaundice on follow up after 4 weeks led to detailed investigations. Ultrasound and doppler study of abdomen
revealed drainage of portal vein into inferior vena cava. CT angiography was performed which confirmed the
diagnosis of Type 1 b Abernethy malformation without associated major anomalies. We discuss the common
clinical presentations, associated anomalies, diagnostic workup and treatment options of this disorder.
Conclusion: The treatment of the patients with congenital porto-systemic shunts depends on the site of the shunt,
associated congenital anomalies and the extent of liver damage but the prognosis depends on the complications
irrespective of anatomical type. However, the extent of associated abnormalities should not deter paediatricians to
refer patients for treatment. Whenever possible closure of the shunt should be advised for cure or to prevent
complications. Only symptomatic type I patients with absence of possibility to close the shunt may require liver
transplant. Long-term follow-up is indicated for all patients.
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John Abernethy first reported congenital absence of portal
vein and congenital mesenterico-caval shunt in 1793 [1].
Abernethy malformation is defined as congenital diversion
of portal blood away from the liver by either end-to-side or
side-to-side shunt [2]. Morgan and Superina [3] classified
congenital extrahepatic portosystemic shunt (CEPSh) into
two types (See Table 1). Till the year 2008 only forty cases
of CEPSh type I and twenty-two of CEPSh type II, had
been described in literature [4,5]. This is despite the tre-
mendous advances in the diagnostic medical imaging, thus
underpinning the rarity of these cases. Only one paediatric
case has been reported from India [6]. In this article we de-
scribe a patient diagnosed to have type I b Abernethy mal-
formation after prolonged jaundice.* Correspondence: drashishp@rediffmail.com
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We present a case of 5 year old girl who presented to
paediatric outpatient clinic of R.D. Gardi Medical College
and C.R. Gardi Hospital, Surasa, Ujjain, India with com-
plains of decreased appetite since past four to five days,
yellowish discoloration of sclera noticed since past two days
and deep yellow coloured urine since past two days. Patient
had no history of clay coloured stools, fever, vomiting,
haematemesis, malena or history suggestive of hepatic en-
cephalopathy. The perinatal history was uneventful with no
history of umbilical sepsis. The child had no significant past
medical history including that of jaundice. Immunization of
the child was appropriate for age. At initial examination her
anthropometric measurements showed a weight of 15 Kg
and a height of 110 cm. The weight-for-age was between
3rd to 15th percentiles; height-for-age between 50th to 85th
percentiles and weight-for-height below 3rd percentile,
according to the WHO Reference Growth Standards 2007
(www.who.int/childgrowth/standard/chart_catalogue ). The
anthropometric findings were suggestive of acute on
chronic malnutrition with stunting. The dietary evaluation
revealed a diet inadequate in calories (by one third), proteinsLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Morgen and Superina [3] classification of
congenital extra hepatic portosystemic shunt
Extra hepatic portosystemic shunts
Type I Absence of intrahepatic portal veins
Type I a Superior mesenteric and splenic vein drain separately
into inferior vena cava
Type I b Superior mesenteric vein and splenic vein form a common
Trunk before draining into the inferior vena cava
Type II Important collateral, patent intrahepatic veins
Figure 1 Contrast enhanced CT scan of upper abdomen with
MIP to include of whole thickness of portal vein shows
aberrant opening of portal vein into inferior vena cava (marked
by white solid arrow in the figure). Note dilated inferior vena
cava cranial to confluence in the image.
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vitals at presentation were heart rate of 120 per minute, re-
spiratory rate of 20 per minute and blood pressure of 98/
60 mm of Hg in right in right upper limb in supine position.
Four-limb blood pressure measurement was also normal. Ic-
terus was noticed. Examination of ears, nose and throat
showed no abnormality. No skin rash was present. No club-
bing, cyanosis or oedema of arms or legs was noted. Cardio-
vascular examination was normal. The lungs were clear on
percussion and auscultation. The abdomen was soft with no
organomegaly or clinical ascites. A provisional diagnosis of
acute viral hepatitis was made based on history, clinical
examination and local endemicity of acute viral hepatitis
caused by hepatitis A or hepatitis E. Only blood investigation
advised was serum bilirubin, which showed total bilirubin
9.29 mg/dl with direct bilirubin of 7.38 mg/dl and indirect
bilirubin of 2.41 mg/dl. Patient was treated symptomatically
for viral hepatitis and asked to follow up if any danger signs
of acute viral hepatitis appear or after 4 weeks. No serological
confirmation of viral hepatitis was deemed necessary in view
of acute viral hepatitis caused by hepatitis A virus being an
endemic disease in the geographic region.
Patient followed four weeks later with persistence of
yellowish discoloration of sclera but had no other symp-
toms. Her clinical examination was unremarkable. A liver
profile, complete blood counts and abdominal ultrasonog-
raphy (USG) were ordered. The complete blood counts
were within normal limits and did not reveal any evidence
of hypersplenism. The liver profile showed total bilirubin
3.4 mg/dl with direct bilirubin of 3.23 mg/dl and indirect
bilirubin of 0.22 mg/dl; aspartate transaminase (AST)
98.2 IU/L (normal values 15–46 IU/L); alanine transamin-
ase (ALT) 109.3 IU/L (normal values 13–69 IU/L); alkaline
phosphatase 269.3(normal values 38–126 IU/L); prothom-
bin time (PT) 14 with control of 16; INR 1.2. Abdominal
ultrasound showed course ecotexture of the liver with
anomalous portal vein. The size of portal vein was 8 mm.
The portal vein drained into inferior vena cava. A CT angi-
ography was advised following the above abdominal ultra-
sound report. The contrast enhanced CT scan of upper
abdomen with MIP to include of whole thickness of portal
vein revealed that the superior mesenteric vein and thesplenic vein join to form a confluence that drained directly
in the inferior vena cava. The portal vein drained in the in-
ferior vena cava at the level of head of pancreas caudal to
the intrahepatic portion (Figure 1 and 2). A dilated inferior
vena cava is seen in Figure 2. The CT scan also showed a
mass lesion in right lobe of liver probably an adenoma or
focal nodular hyperplasia (Figure 2). In view of the above
features and absence of portal vein radicals in liver paren-
chyma a diagnosis of Abernethy malformation type 1 b
was made. To complete the work up a fasting blood sugar
and serum ammonia was done which were normal. (Blood
sugar 71 mg/L and serum ammonia 20 μgm/dL (normal
values 10–80 μgm/dL). A skeletal survey did not show any
skeletal abnormalities. An echocardiogram with colour
doppler did not show any associated congenital cardiac
defects.
Consent
Written informed consent was obtained from the
patient’s father for publication of this case report and ac-
companying images.
Discussion
Due to the endemicity of acute viral hepatitis caused by
hepatitis A and hepatitis E most clinicians do not inves-
tigate a typical “viral hepatitis” case. In the present case
the jaundice can be explained only by the viral hepatitis
alone. But persistence of jaundice led us to investigate
the present case. Thus, the possibility of missing a diag-
nosis in resource poor setting is high where both the
diagnostic facilities and follow up of patients is often in-
adequate. However, one more basic indicator pointing
towards a chronic disease were the anthropometric
Figure 2 CT scan abdomen: Mass lesion in right lobe of liver
(marked by white solid arrow).
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and follow-up of disease course is illustrated in this case.
We now discuss various possible clinical presentations
and associated congenital anomalies of the Abernethy
malformations followed by diagnostic workup and treat-
ment options.
Congenital intra-hepatic portosystemic shunts can present
in the early neonatal period with growth restriction [7], galac-
tosemia [8-10], neonatal cholestasis [11], and hepatic enceph-
alopathy [12]. Cases of CEPSh have a variable presentation.
In countries having neonatal screening programmes, some
cases can be diagnosed by neonatal screening tests due to
presence of galactosemia [8-10]. Many patients are diagnosed
due to associated defects like heart disease, which are present
in up-to 60% of the patients [4,12-14]. Symptoms of second-
ary complications like hypoglycemia, hyperammonemia, en-
cephalopathy and cardiac failure can be transient and can
resolve spontaneously [12]. Subclinical course is more com-
mon and some patients might not have any symptoms
throughout life [12,13,15]. Later, other lesions like nodular
regenerative hyperplasia, partial nodular transformation,
hepatoblastoma, hepatocellular carcinoma and adenoma can
develop [4].
The two possible explanations of development of these
neoplasm are: a) diversion of hepatotrophic substances
like insulin and glucagon away from liver leading to
altered development, function and regenerative capacity
of the liver and b) increased arterial hepatic flow [4].
Our patient does not have any evidence of hepatic neo-
plasm (normal alfa feto protein) at present after more
than two year follow up, however in view of the docu-
mented increased risk of hepatocellular carcinoma and
adenoma we have advised a regular radiological and
serological surveillance at six monthly interval.
Despite presence of porto-systemic shunt, patients
with CEPSh usually do not present with encephalopathy.Hyperammonemia may be present without encephalop-
athy especially at younger age. Clinical encephalopathy
is more common at older age. The possible explanations
are a) an increased sensitivity of the aging brain to toxic
effects of ammonia and other toxic metabolites b) extent
of shunt determined by the portal/systemic shunt ratio.
A shunt ratio of more than 60% may predict the age of
onset of hepatic encephalopathy [6,16]. In our case, the
ammonia concentration was within normal range and
patient has had no clinical evidence of encephalopathy
till date.
Varying degree of dyspnoea on exertion could be a
presentation of portopulmonary hypertension or hepato-
pulmonary syndrome. Hepatopulmonary syndrome pre-
sents with hypoxemia and or orthopnea with clubbing;
due to abnormal intrapulmonary vascular dilatations
[13,17]. In our patient there is no evidence of hepatopul-
monary syndrome, till date clinically as well as on
echocardiography.
Congenital hepatic shunt can also present with
hypoglycaemia. This might be due to combined effect of
defective uptake of glucose and hyperinsulinemia due to
reduced hepatic degradation of normal quantity of
secreted insulin [18]. A work up of common associated
anomalies was done but revealed no anomaly. These in-
clude cardiac defects (60%), biliary atresia (20%), poly-
splenia (20%), situs inversus (10%) and malrotation
(10%) [14,19].
A diagnosis of Abernethy malformation is made by
non-invasive cross-sectional imaging techniques such as
ultrasound, CT or MRI, which show the shunt and any
intrahepatic portal vein branches [17].
The planning of treatment is dependent on the type of
shunt as classified by Morgan and Superina [3] and needs
to be tailored to the individual patient in accordance with
preoperative evaluation [15]. Usually in patients with
CEPSh type I, occlusion of shunt is not performed, as it is
the only drainage route for the mesenteric venous blood.
But recently published experience by several authors
[15,17] point that many patients with CEPSh type I mal-
formations might have small portal vein radicals which
cannot be seen on ultrasonography but could be visualized
on shunt angiography. The balloon occlusion test of the
fistula can also be done [15,17]. This test helps to decide
on a single stage or a two-staged shunt closure procedure.
A two-step procedure allows the portal branches to en-
large slowly and can avoid acute severe portal hyperten-
sion [15,17]. Extremely hypoplastic or undetectable portal
veins will require banding of the fistula before closure
[17]. Shunt closure results in restoration of intrahepatic
portal flow in most patients [17]. Clinical improvement in
form of regression of benign liver masses, and regression
or stabilization of pulmonary, cardiac, neurological, and
renal complications is seen in patients post shunt [17].
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imaging follow-up [17]; as is done in our patient. For
patients with CEPSh type I developing complications like
encephalopathy or neoplasms, till recently liver transplant
was the only treatment option [6,15,19,20], but transplant
should be reserved for exceptionally complex anatomy
where closure of the shunt is not possible.
Patients with CEPSh type II with hepatic encephalopathy
can benefit by early shunt occlusion surgery [15,17].
Reconstruction of the portal vein should be done early to
avoid mesenteric venous congestion [20]. Shunt surgery
when possible is the treatment of choice for CEPSh type I
and type II. Our patient is asymptomatic at present but
since the patient has nodular lesion in the liver she should
be considered “symptomatic”. In view of this our patient
has been counselled for need for shunt surgery.
Conclusions
Persistence of jaundice should be investigated at all ages.
Ultrasound is useful tool for screening of congenital
anomalies associated with liver. In resource poor settings
the diagnosis of portosystemic shunts can be missed or
significantly delayed due to lack of resources need for the
diagnosis, including availability of trained ultra-sonologists.
The prognosis of the patients with congenital portosystemic
shunts depends on the site of the shunt as determined by
Morgan and Superina classification, the associated congeni-
tal anomalies and the extent of liver disease. Many patients
will benefit from shunt surgery. The extent of associated
abnormalities should not deter paediatricians to refer
patients for treatment. A long-term follow-up is indicated
for all asymptomatic patients of Abernethy malformation.
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